Entrada Therapeutics, Inc. (TRDA) SEC Filings — 2025
13 SEC filings for Entrada Therapeutics, Inc. (TRDA) in 2025.
Filings
- Entrada's Q3 Loss Widens Amid Steep Drop in Collaboration Revenue — 10-Q · Nov 6, 2025
- Entrada's Losses Widen Amid Increased R&D Spend, No Revenue — 10-Q · Aug 6, 2025
- Entrada Therapeutics Files 8-K on Security Holder Vote — 8-K · Jun 11, 2025
- Entrada Therapeutics Files Proxy Statement — DEFA14A · Jun 3, 2025
- Entrada Therapeutics Appoints New CMO, Elects Director — 8-K · Jun 3, 2025
- Entrada Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Entrada Therapeutics Reports Exit Costs — 8-K · Apr 29, 2025
- Entrada Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 25, 2025
- Entrada Therapeutics Files 8-K — 8-K · Mar 24, 2025
- Entrada Therapeutics, Inc. 10-K Filing — 10-K · Feb 27, 2025
- Entrada Therapeutics Files 8-K — 8-K · Feb 24, 2025
- Entrada Therapeutics Files 8-K — 8-K · Feb 3, 2025
- Entrada Therapeutics 8-K Filing: Corporate Office Update — 8-K · Jan 15, 2025